Arvidsson L, Lindgren S, Martinell L, Lundin S, Rylander C
Department of Anaesthesiology and Intensive Care Medicine, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Acta Anaesthesiol Scand. 2017 Oct;61(9):1176-1183. doi: 10.1111/aas.12957. Epub 2017 Aug 16.
Intensive care for comatose survivors of cardiac arrest includes targeted temperature management (TTM) to attenuate cerebral reperfusion injury. A recent multi-center clinical trial did not show any difference in mortality or neurological outcome between TTM targeting 33°C or 36°C after out-of-hospital-cardiac-arrest (OHCA). In our institution, the TTM target was changed accordingly from 34 to 36°C. The aim of this retrospective study was to analyze if this change had affected patient outcome.
Intensive care registry and medical record data from 79 adult patients treated for OHCA with TTM during 2010 (n = 38; 34°C) and 2014 (n = 41; 36°C) were analyzed for mortality and neurological outcome were assessed as cerebral performance category. Student's t-test was used for continuous data and Fischer's exact test for categorical data, and multivariable logistic regression was applied to detect influence from patient factors differing between the groups.
Witnessed arrest was more common in 2010 (95%) vs. 2014 (76%) (P = 0.03) and coronary angiography was more common in 2014 (95%) vs. 2010 (76%) (P = 0.02). The number of patients awakening later than 72 h after the arrest did not differ. After adjusting for gender, hypertension, and witnessed arrest, neither 1-year mortality (P = 0.77), nor 1-year good neurological outcome (P = 0.85) differed between the groups.
Our results, showing no difference between TTM at 34°C and TTM at 36°C as to mortality or neurological outcome after OHCA, are in line with the previous TTM-trial results, supporting the use of either target temperature in our institution.
对心脏骤停昏迷幸存者的重症监护包括进行目标温度管理(TTM)以减轻脑再灌注损伤。最近一项多中心临床试验表明,院外心脏骤停(OHCA)后将目标温度设定为33°C或36°C的TTM在死亡率或神经功能结局方面并无差异。在我们机构,TTM目标温度相应地从34°C改为36°C。这项回顾性研究的目的是分析这一变化是否影响了患者的结局。
分析了2010年(n = 38;34°C)和2014年(n = 41;36°C)接受OHCA的TTM治疗的79例成年患者的重症监护登记和病历数据,评估死亡率和神经功能结局,以脑功能分类表示。连续数据采用学生t检验,分类数据采用费舍尔精确检验,并应用多变量逻辑回归分析来检测两组间不同患者因素的影响。
2010年目击心脏骤停更为常见(95%),而2014年为(76%)(P = 0.03);2014年冠状动脉造影更为常见(95%),而2010年为(76%)(P = 0.02)。心脏骤停后72小时后苏醒的患者数量没有差异。在调整性别、高血压和目击心脏骤停因素后,两组间1年死亡率(P = 0.77)和1年良好神经功能结局(P = 0.85)均无差异。
我们的结果表明,OHCA后34°C的TTM和36°C的TTM在死亡率或神经功能结局方面没有差异,这与之前的TTM试验结果一致,支持在我们机构使用任一目标温度。